The authors reported that JAK-STAT signalling activity regulates the contrasting secretome of ERα positive and ERα negative breast cancer cells, through differential cytokine (IL6, IL12RB2) secretion dependent on estrogen receptor status, acting as a key regulator of JAK-STAT phosphorylation (Figure 2). The gene discussed is SOAT1; the disease is breast carcinoma.